Chronic disease patients' risk of dying higher if they also have a psychiatric disorder

Publicly released:
International
Photo by Ben Blennerhassett on Unsplash
Photo by Ben Blennerhassett on Unsplash

People with chronic diseases such as diabetes or heart disease have more than twice the risk of death if they also have a psychiatric disorder, according to international research. The team used Swedish national registers to compare five-year outcomes for people diagnosed with a chronic disease with or without an additional psychiatric disorder. They say having both a psychiatric disorder and chronic disease was associated with a 15.4  -21.1 per cent risk of dying of any cause, compared to 5.5-9.1 per cent for those with chronic disease only.

Media release

From: PLOS

Psychiatric disease associated with increased risk of death from cardiovascular disease and diabetes

Among patients with chronic, non-communicable diseases, the risk of death is more than doubled if they also have a psychiatric comorbidity, according to a new study publishing January 27th in PLOS Medicine by Seena Fazel of the University of Oxford, UK, and colleagues.

Non-communicable diseases such as diabetes and heart disease are a global public health challenge accounting for an estimated 40 million excess deaths annually. In the new study, researchers used national registers in Sweden to investigate more than 1 million patients born between 1932 and 1995 who had diagnoses of chronic lung disease, cardiovascular disease, and diabetes. More than a quarter (25-32%) of people in the analysis had a co-occurring lifetime diagnosis of any psychiatric disorder.

Within 5 years of diagnosis, 7% (range 7.4%-10.8%; P<0.001) of the people included in the study had died from any cause and 0.3% (0.3%-0.3%; P<0.001) had died from suicide. Comorbid psychiatric disorders were associated with higher all-cause mortality (15.4%-21.1%) when compared to those without such conditions (5.5%-9.1%). When the researchers compared each patient with an unaffected sibling, to account for familial risk factors, psychiatric comorbidity remained consistently associated with elevated rates of premature mortality and suicide (adjusted HR range: aHRCL=7.2 [95% CI: 6.8-7.7; P<0.001] to aHRCV =8.9 [95% CI: 8.5-9.4; P<0.001]). Risks ranged by psychiatric diagnosis; for instance, mortality risks were elevated by 8.3-9.9 times in those with comorbid substance use disorder compared to unaffected siblings, and by 5.3-7.4 times in those with comorbid depression. One limitation of the study is that the use of population-based registries to identify patients means that psychiatric comorbidities were diagnosed in specialty care settings and that undiagnosed individuals and those with less severe psychiatric illness could be missed.

“Improving assessment, treatment, and follow-up of people with comorbid psychiatric disorders may reduce the risk of mortality in people with chronic non-communicable diseases,” the authors say.

“We used electronic health records to investigate over 1 million patients diagnosed with chronic lung diseases, cardiovascular diseases, and diabetes,” Fazel adds. “More than 7% of the patients died of any cause within five years and 0.3% died from suicide – risks that were more than doubled in patients with psychiatric comorbidities compared to those without such comorbidities.”

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research PLOS, Web page The URL will go live after the embargo ends
Journal/
conference:
PLOS Medicine
Research:Paper
Organisation/s: Oxford University, UK
Funder: This research was funded by the Wellcome Trust, project: #202836/Z/16/Z (https://wellcome.org/), to SF; the Swedish Research Council for Health, Working Life and Welfare, 2012-1678 (https://forte.se/en/), to PL; the Swedish Research Council, project: 2016-01989 (https://www.vr.se/), to PL, and the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care Oxford at Oxford Health NHS Foundation Trust (https://www.clahrc-oxford.nihr.ac.uk/) to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Media Contact/s
Contact details are only visible to registered journalists.